Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Alnylam: Rally On No News Leaves Room For Downside
Seeking Alpha
Thursday, January 24, 2013 - 10:35am
tags:
Alnylam, Isis Pharmaceuticals
Biogen’s Longer-Lasting MS Drug Meets Goals in Late Trial
Bloomberg
Thursday, January 24, 2013 - 10:33am
tags:
MS, Biogen Idec, multiple sclerosis, peginterferon beta-1a
Celgene Earnings: These Results Have Investors Guessing
Wall St. Cheat Sheet
Thursday, January 24, 2013 - 10:31am
tags:
earnings, Celgene
Arena Stumbles On EMA Concerns Over Belviq Ahead Of Launch
Seeking Alpha
Thursday, January 24, 2013 - 10:30am
tags:
Europe, Belviq, Arena Pharmaceuticals
Amarin announces market introduction of Vascepa capsules for treatment of VHTG
Yahoo/Fly on the Wall
Thursday, January 24, 2013 - 10:29am
tags:
Amarin, Vascepa
The Market Waits For NovaBay
Seeking Alpha
Thursday, January 24, 2013 - 10:28am
tags:
NovaBay
1 Undervalued Generic Producer and 1 Peer Stock With Momentum
Motley Fool
Thursday, January 24, 2013 - 10:27am
tags:
generics, Mylan, Teva
Cubist Pharma Earnings: A Mixed Reaction to Analyst Estimates
Wall St. Cheat Sheet
Thursday, January 24, 2013 - 10:27am
tags:
earnings, Cubist Pharmaceuticals
AstraZeneca: Results Preview
Motley Fool
Thursday, January 24, 2013 - 10:25am
tags:
earnings, Astra Zeneca
Bristol-Myers beats forecasts, as newer drugs deliver
Reuters
Thursday, January 24, 2013 - 10:23am
tags:
earnings, Bristol-Myers Squibb
This Is the Most Exciting IPO of the Year
Motley Fool
Thursday, January 24, 2013 - 9:53am
tags:
IPOs, Zoetis, Pfizer, animal health
Atrial fibrillation: nContact wins FDA clearance for cardiac device
Mass Device
Wednesday, January 23, 2013 - 9:26pm
tags:
atrial fibrillation, FDA, cadiac, devices, regulatory
1 in 3 metal hips may fail in under 5 years, J&J analysis finds
Mass Device
Wednesday, January 23, 2013 - 9:25pm
tags:
hip, implants, patient, Johnson & Johnson, safety, devices
Covidien touts EU win for EverFlex stent
Mass Device
Wednesday, January 23, 2013 - 9:24pm
tags:
Covidien, EU, EverFlex, stent
Allergan drops $958M on migraine drug maker MAP Pharma
Mass Device
Wednesday, January 23, 2013 - 9:24pm
tags:
Allergan, M&A, migraine
Covidien snags CE mark for self-expanding stent
FierceMedicalDevice
Wednesday, January 23, 2013 - 9:14pm
tags:
Covidien, CE Mark, stent
After FDA ban, Hospira creeps back into the infusion game with Q Core deal
FierceMedicalDevice
Wednesday, January 23, 2013 - 9:14pm
tags:
FDA, Hospira, infusion
Abbott faces lagging stent sales in drug-free future
FierceMedicalDevice
Wednesday, January 23, 2013 - 9:13pm
tags:
Abbott Laboratories, stent, sales, devices
St. Jude Medical Reports Fourth Quarter and Full-Year 2012 Results
Yahoo/BusinessWire
Wednesday, January 23, 2013 - 9:09pm
tags:
St. Jude Medical, earnings, devices
Intuitive Surgical rises 9 pct. on strong earnings
Yahoo/AP
Wednesday, January 23, 2013 - 9:07pm
tags:
Intuitive Surgical, stock, earnings, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.